195155-81-8

Basic information

• Product Name: N-n-butyl-3β,22β-dibenzyloxyolean-12-ene-24-amide
• Synonyms: N-n-butyl-3β,22β-dibenzyloxyolean-12-ene-24-amide
• CAS NO: 195155-81-8
• Molecular Weight: 708.081
• Mol File: 195155-81-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-n-butyl-3β,22β-dibenzyloxyolean-12-ene-24-amide(CAS DataBase Reference)
• NIST Chemistry Reference: N-n-butyl-3β,22β-dibenzyloxyolean-12-ene-24-amide(195155-81-8)
• EPA Substance Registry System: N-n-butyl-3β,22β-dibenzyloxyolean-12-ene-24-amide(195155-81-8)

Safety Data

• Hazardous Substances Data: 195155-81-8(Hazardous Substances Data)

Upstream product

• 124862-79-9 soyasapogenol B 
• 186415-73-6 ((3S,4S,4aR,6aR,6bS,8aR,9R,12aS,14aR,14bR)-3,9-Bis-benzyloxy-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydro-picen-4-yl)-methanol 
• 186415-77-0 C₄₄H₆₀O₃ 
• 186415-74-7 (3S,4R,4aR,6aR,6bS,8aR,9R,12aS,14aR,14bR)-3,9-Bis-benzyloxy-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydro-picene-4-carbaldehyde 
• 187394-38-3 3,24-O-benzylidene soyasapogenol B 
• 187393-81-3 3β,22β-dibenzyloxy-24-trityloxyolean-12-ene 
• 83689-13-8 (3S,4S,4aR,6aR,6bS,8aR,9R,12aS,14aR,14bR)-4,6a,6b,8a,11,11,14b-Heptamethyl-4-trityloxymethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydro-picene-3,9-diol 
• 100-39-0 benzyl bromide 
• 1125-88-8 benzaldehyde dimethyl acetal 
• 109-73-9 N-butylamine 
• 187393-82-4 (3S,4R,4aR,6aR,6bS,8aR,9R,12aS,14aR,14bR)-3,9-Bis-benzyloxy-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydro-picene-4-carboxylic acid 

Relevant articles and documents

Preventive effects of soyasapogenol B derivatives on liver injury in a concanavalin A-induced hepatitis model

To shed light on the structure-activity relationship, various soyasapogenol B derivatives were synthesized and evaluated for preventive effects on liver injury in the concanavalin A (Con A)-induced hepatitis model in mice. Con A injection into mice induces some pathophysiology of human liver disease such as autoimmune or viral hepatitis. Two hydroxyl groups on the A ring of soyasapogenol B are required for amelioration of liver damage. Modification of the C-22 hydroxyl moiety with an acyloxy or alkyloxy group, or removal of the hydroxyl group, resulted in a greatly enhanced percentage of alleviation. Among the series of soyasapogenol B derivatives examined, six compounds exhibited preventive effects on liver damage.